The UFC was notified on Tuesday that Brock Lesnar failed a second drug test, this time from a sample collected on his UFC 200 fight day.

The UFC released the following statement on Tuesday:

“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.

“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.

“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”

Lesnar was previously flagged for a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on June 28, 2016.